Acceptability of receiving lifestyle advice at cervical, breast and bowel cancer screening

Claire Stevens, Charlotte Vrinten, Samuel G Smith, Jo Waller, Rebecca J Beeken, Claire Stevens, Charlotte Vrinten, Samuel G Smith, Jo Waller, Rebecca J Beeken

Abstract

Cancer screening could be an opportunity to deliver cancer prevention advice, but it is not known how such information would be received. We explored willingness to receive lifestyle advice in the context of the English National Health Service cervical, breast, and bowel (FS; flexible sigmoidoscopy) screening programmes. A population-based survey was conducted in 2016 to collect nationally representative data on willingness to receive lifestyle advice across cervical (n = 768), breast (n = 420) and FS (n = 308) screening programmes. Additional items assessed the impact of lifestyle advice on screening attendance, preference for receiving advice in the event of an abnormal screening result, and timing of advice. Most respondents were willing to receive lifestyle advice around the time of cancer screening (cervical 78.9%, breast 79.4%, FS 81.8%), and if their results were abnormal (cervical 86.3%, breast 83.0%, FS 85.1%). A small proportion indicated it may discourage future attendance (cervical 4.9%, breast 7.0%, FS 8.8%). Most preferred information to be delivered at the screening appointment (cervical 69.8%, breast 72.6%, FS 70.7%). There were no associations between sociodemographic characteristics and willingness to receive lifestyle advice at breast screening. For those intending to attend cervical screening, non-White ethnicity and higher education were associated with increased willingness to receive lifestyle advice. Women were more likely to be willing to receive advice at FS screening than men. Providing lifestyle advice at cancer screening is likely to be acceptable to the general population. The optimal approach for delivery needs careful consideration to minimise potential negative effects on screening attendance.

Keywords: Behaviour change; Cancer prevention; Cancer screening; Lifestyle; Teachable moment.

Copyright © 2019 The Authors. Published by Elsevier Inc. All rights reserved.

Figures

Fig. 1
Fig. 1
Impact of the provision of lifestyle advice on willingness to attend cancer screening, among participants who intend to attend their next cancer screening appointment. 1 Flexible sigmoidoscopy.

References

    1. Anderson A.S., Mackison D., Boath C., Steele R. Promoting changes in diet and physical activity in breast and colorectal cancer screening settings: an unexplored opportunity for endorsing healthy behaviors. Cancer Prev. Res. 2013;6:165–172.
    1. Anderson A.S., Craigie A.M., Caswell S., Treweek S., Stead M., Macleod M., Daly F., Belch J., Rodger J. The impact of a bodyweight and physical activity intervention (BeWEL) initiated through a national colorectal cancer screening programme: randomised controlled trial. BMJ. 2014;348
    1. Anderson A.S., Macleod M., Mutrie N., Sugden J., Dobson H., Treweek S., O'Carroll R.E., Thompson A., Kirk A. Breast cancer risk reduction-is it feasible to initiate a randomised controlled trial of a lifestyle intervention programme (ActWell) within a national breast screening programme? Int. J. Behav. Nutr. Phys. Act. 2014;11:156.
    1. Baker A.H., Wardle J. Increasing fruit and vegetable intake among adults attending colorectal cancer screening: the efficacy of a brief tailored intervention. Cancer Epidemiol. Biomark. Prev. 2002;11:203–206.
    1. Brown K.F., Rumgay H., Dunlop C., Ryan M., Quartly F., Cox A., Deas A., Elliss-Brookes L., Gavin A. The fraction of cancer attributable to modifiable risk factors in England, Wales, Scotland, Northern Ireland, and the United Kingdom in 2015. Br. J. Cancer. 2018;118:1130–1141.
    1. Cahill K., Lancaster T. Workplace interventions for smoking cessation. Cochrane Database Syst. Rev. 2014
    1. Cancer Research U.K. Cancer Incidence for All Cancers Combined. 2016.
    1. Chellini E., Gorini G., Gasparrini A., Grazzini G., Iossa A., Martellucci P.M., Terrone R. Cervical cancer screening visit as an occasion for counseling female smokers to quit. Tumori. 2012;98:27–32.
    1. Conway E., Wyke S., Sugden J., Mutrie N., Anderson A.S., Team A. Can a lifestyle intervention be offered through NHS breast cancer screening? Challenges and opportunities identified in a qualitative study of women attending screening. BMC Public Health. 2016;16:758.
    1. Courtenay W.H. Constructions of masculinity and their influence on men's well-being: a theory of gender and health. Soc. Sci. Med. 2000;50:1385–1401.
    1. Cutler D.M., Lleras-Muney A. Understanding differences in health behaviors by education. J. Health Econ. 2010;29:1–28.
    1. Douglas E., Waller J., Duffy S.W., Wardle J. Socioeconomic inequalities in breast and cervical screening coverage in England: are we closing the gap? J. Med. Screen. 2016;23:98–103.
    1. Edwards B.K., Ward E., Kohler B.A., Eheman C., Zauber A.G., Anderson R.N., Jemal A., Schymura M.J., Lansdorp-Vogelaar I. Annual report to the nation on the status of cancer, 1975–2006, featuring colorectal cancer trends and impact of interventions (risk factors, screening, and treatment) to reduce future rates. Am. Cancer Soc. 2010;116:544–573.
    1. Fisher B., Dowding D., Pickett K.E., Fylan F. Health promotion at NHS breast cancer screening clinics in the UK. Health Promot. Int. 2007;22:137–145.
    1. Friedenreich C.M., Woolcott C.G., McTiernan A., Terry T., Brant R., Ballard-Barbash R., Irwin M.L., Jones C.A., Boyd N.F. Adiposity changes after a 1-year aerobic exercise intervention among postmenopausal women: a randomized controlled trial. Int. J. Obes. 2011;35:427–435.
    1. Gorini G., Carreras G., Giordano L., Anghinoni E., Iossa A., Coppo A., Talassi F., Galavotti M., Chellini E. The pap smear screening as an occasion for smoking cessation and physical activity counselling: effectiveness of the SPRINT randomized controlled trial. BMC Public Health. 2012;12:740.
    1. Hall S., Bishop A.J., Marteau T.M. Increasing readiness to stop smoking in women undergoing cervical screening: evaluation of two leaflets. Nicotine Tob. Res. 2003;5:821–826.
    1. Hall S., Reid E., Ukoumunne O.C., Weinman J., Marteau T.M. Brief smoking cessation advice from practice nurses during routine cervical smear tests appointments: a cluster randomised controlled trial assessing feasibility, acceptability and potential effectiveness. Br. J. Cancer. 2007;96:1057–1061.
    1. Health and Social Care Information Centre Breast Screening Programme, England: Statistics for 2014–15. 2016.
    1. Health and Social Care Information Centre Cervical screening programme, England Statistics for 2014–15. 2016.
    1. Joshu C.E., Parmigiani G., Colditz G.A., Platz E.A. Opportunities for the primary prevention of colorectal cancer in the United States. Cancer Prev. Res. (Phila.) 2012;5:138–145.
    1. Lawson P.J., Flocke S.A. Teachable moments for health behavior change: a concept analysis. Patient Educ. Couns. 2009;76:25–30.
    1. Macleod M., Anderson A.S. Cancer prevention the feasibility and acceptability of promoting breast cancer risk reduction in the screening setting through a lifestyle magazine. Eur. J. Cancer Care. 2018;27
    1. McBride C.M., Scholes D., Grothaus L.C., Curry S.J., Ludman E., Albright J. Evaluation of a minimal self-help smoking cessation intervention following cervical cancer screening. Prev. Med. 1999;29:133–138.
    1. McGregor L.M., Bonello B., Kerrison R.S., Nickerson C., Baio G., Berkman L., Rees C.J., Atkin W., Wardle J. Uptake of bowel scope (flexible sigmoidoscopy) screening in the English national programme: the first 14 months. J. Med. Screen. 2016;23:77–82.
    1. Moser K., Patnick J., Beral V. Inequalities in reported use of breast and cervical screening in Great Britain: analysis of cross sectional survey data. Br. Med. J. 2009:338.
    1. Pampel F.C., Krueger P.M., Denney J.T. Socioeconomic disparities in health behaviors. Annu. Rev. Sociol. 2010;36:349–370.
    1. Public Health England Making every contact count (MECC): Consensus statement. 2016.
    1. Public Health England NHS screening programmes in England: 1 April 2015 to 31 March 2016. 2016.
    1. Robb K.A., Power E., Atkin W., Wardle J. Ethnic differences in participation in flexible sigmoidoscopy screening in the UK. J. Med. Screen. 2008;15:130–136.
    1. Robb K.A., Power E., Kralj-Hans I., Atkin W.S., Wardle J. The impact of individually-tailored lifestyle advice in the colorectal cancer screening context: a randomised pilot study in north-West London. Prev. Med. 2010;51:505–508.
    1. Senore C., Giordano L., Bellisario C., Di Stefano F., Segnan N. Population based cancer screening programmes as a teachable moment for primary prevention interventions. A review of the literature. Front. Oncol. 2012;2:45.
    1. Sheeran P. Intention—behavior relations: a conceptual and empirical review. Eur. Rev. Soc. Psychol. 2002;21:1–36.
    1. Smittenaar C.R., Petersen K.A., Stewart K., Moitt N. Cancer incidence and mortality projections in the UK until 2035. Br. J. Cancer. 2016;115:1147–1155.
    1. Stevens C., Vrinten C., Smith S.G., Waller J., Beeken R.J. Determinants of willingness to receive healthy lifestyle advice in the context of cancer screening. Br. J. Cancer. 2018;119:251–257.
    1. Stringhini S., Dugravot A., Shipley M., Goldberg M., Zins M., Kivimaki M., Marmot M., Sabia S., Singh-Manoux A. Health behaviours, socioeconomic status, and mortality: further analyses of the British Whitehall II and the French GAZEL prospective cohorts. PLoS Med. 2011;8
    1. The Independent Cancer Taskforce Achieving world-class cancer outcomes: a strategy for England 2015–2020. 2015.
    1. von Wagner C., Baio G., Raine R., Snowball J., Morris S., Atkin W., Obichere A., Handley G., Logan R.F. Inequalities in participation in an organized national colorectal cancer screening programme: results from the first 2.6 million invitations in England. Int. J. Epidemiol. 2011;40:712–718.

Source: PubMed

Szponzorok és közreműködők

Egészségi állapot

Kábítószer-beavatkozások

3
Iratkozz fel